The size of Intravenous Immunoglobulin (IVIG) market globally reached USD 11.23 Billion in 2021, and it is projected to experience a revenue compound annual growth rate (CAGR) of 6.9% during the forecast period. Factors such as the increasing prevalence of immunodeficiency diseases, advancements in technology, investments in the field, growing adoption of immunoglobulin therapies, and a rising...